Early Post-Transplant Recipient Tissue Injury Predicts Allograft Function, Rejection, and Survival in Lung Transplant Recipients, Evidence from Cell-free DNA
European Respiratory Journal · 2025
DOI: 10.1183/13993003.02537-2024 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Respiratory Journal, 2025. Verfasst von Muhtadi Alnababteh und 18 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Applied Precision Omics (APO), National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health, Bethesda, MD, USA. Hauptthemen laut MEDLINE: Lung Transplantation, Cell-Free Nucleic Acids, Graft Rejection. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHLBI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Background
Allograft injury in the early post-transplant period is a known risk factor of death after lung transplantation. However, the recipient tissue injury profile and its association with outcomes remain unexplored. This study leverages cell-free DNA (cfDNA) to test this association.
Methods
The prospective cohort multicenter study included lung transplant recipients (GRAfT, NCT02423070 ) with serial plasma measurements of recipient-derived (rd)-cfDNA using digital droplet PCR. Non-transplant healthy controls were recruited as the comparator. Whole-genome bisulfite sequencing identified tissue sources of cfDNA. Mean rd-cfDNA levels within 30 days post-transplant was computed. Multivariable regression models were used to assess the association between rd-cfDNA tertiles and the primary outcome of death and secondary outcomes.
Results
The study included 215 patients with 2530 cfDNA values, including 675 cfDNA assessments in the first 30 days. Median rd-cfDNA levels in the first 30 days post-transplant were ∼16-fold higher than cfDNA for healthy controls. Patients in the highest tertile rd-cfDNA group had lower lung function post-transplant, and increased risk of death (HR: 3.15, 95% CI: 1.59–6.24, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Applied Precision Omics (APO), National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health, Bethesda, MD, USA.
- Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
- Genomic Research Alliance for Transplantation (GRAfT), USA.
- Pulmonary and Critical Care Medicine, University of Maryland, Baltimore, MD, USA.
- Division of Hospital Medicine, Johns Hopkins Bayview Medical Center, Baltimore, MD, USA.
- Pulmonary and Critical Care Medicine, Johns Hopkins Hospital, Baltimore, MD, USA.
ORCID-Profile: Steven D Nathan
Förderung
- NHLBI NIH HHS
- National Institutes of Health
Zitieren
APA
Alnababteh, M., Keller, M. B., Kong, H., Phipps, K., Namian, J., Ponor, L., Shah, P., Mathews, J., Andargie, T., Park, W., Orens, J. B., Aryal, S., Nathan, S. D., Bush, E., Redekar, N., Hill, T., Jang, M., Tian, X., & Agbor-Enoh, S. (2025). Early Post-Transplant Recipient Tissue Injury Predicts Allograft Function, Rejection, and Survival in Lung Transplant Recipients, Evidence from Cell-free DNA. European Respiratory Journal. https://doi.org/10.1183/13993003.02537-2024
Vancouver
Alnababteh M, Keller MB, Kong H, Phipps K, Namian J, Ponor L, et al. Early Post-Transplant Recipient Tissue Injury Predicts Allograft Function, Rejection, and Survival in Lung Transplant Recipients, Evidence from Cell-free DNA. European Respiratory Journal. 2025. doi:10.1183/13993003.02537-2024
BibTeX
@article{Alnababteh2025,
author = {Alnababteh, Muhtadi and Keller, Michael B and Kong, Hyesik and Phipps, Kellie and Namian, Jackson and Ponor, Lucia and Shah, Pali and Mathews, Joby and Andargie, Temesgen and Park, Woojin and Orens, Jonathan B and Aryal, Shambhu and Nathan, Steven D and Bush, Errol and Redekar, Neelam and Hill, Tom and Jang, Moon and Tian, Xin and Agbor-Enoh, Sean},
title = {Early Post-Transplant Recipient Tissue Injury Predicts Allograft Function, Rejection, and Survival in Lung Transplant Recipients, Evidence from Cell-free DNA},
journal = {European Respiratory Journal},
year = {2025},
doi = {10.1183/13993003.02537-2024}
}
EUVIMED